Aspira Women's Health Inc. 10-Q filing
Filed 2025-11-14 · Report date 2025-09-30 · 2025
Filing metadata
- Accession number
- 0000926617-25-000008
- Form type
- 10-Q
- CIK
- 0000926617
- Primary document
- https://www.sec.gov/Archives/edgar/data/926617/000092661725000008/awhl-20250930x10q.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Aspira Women's Health Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $7.0M | - | - |
| Cost Of Revenue | $2.5M | - | - |
| Gross Profit | $4.5M | - | - |
| Operating Income | $-6.6M | - | - |
| Net Income | $-9.4M | - | - |
| Eps Basic | -0.3 | - | - |
| Eps Diluted | -0.3 | - | - |
| Cash And Equivalents | $3.8M | - | - |
| Total Assets | $7.3M | - | - |
| Total Liabilities | $11.6M | - | - |
| Shareholders Equity | $-4.3M | - | - |
| Operating Cash Flow | $-5.0M | - | - |
| Capital Expenditures | $8,000 | - | - |